Apricus Biosciences announces approval of Vitaros® for treatment of ED in Greece
Apricus announced that Greece has granted Apricus’ commercialization partner, Recordati, market approval for Vitaros®, an on-demand topical cream indicated for treatment of patients with erectile dysfunction. This is the twenty-fifth country in which the product has been approved. October 26, 2016